Delivery Order SPE2DB20D3505-SPE2DB22FT3R3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $1,966.04 for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.43, is for the delivery of Trileptal 300 mg/5 ml suspension, a pharmaceutical product, with a completion date of January 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a $1,890.63 order for the pharmaceutical product Trileptal 300 mg/5 ml suspension. The contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,201.96, is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. This is a firm fixed-price delivery order contract with a completion date of May 11, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of Trileptal 300 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $10,177.84 and an ultimate completion date of September 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution company serving the U.S. federal government, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,049.72, is a delivery order for the supply of Trileptal 300 mg/5 ml suspension. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.99 firm fixed-price contract is for the supply of Trileptal 300 mg/5 ml suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,853.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, with a completion date of May 31, 2023. This contract is not designated as a set-aside and is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award, valued at $5,180.00, is a firm-fixed price contract without any set-aside designation. The period of performance for this delivery order extends through August 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.25 Firm Fixed Price Delivery Order is for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT3R3Delivery Order
This federal contract award is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,063.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price delivery order, without any set-aside designation, and has an ultimate completion date of January 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/4/22 |